Harbor Investment Advisory’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,439
Closed -$11K 1401
2022
Q1
$11K Hold
1,439
﹤0.01% 1041
2021
Q4
$20K Buy
+1,439
New +$21.2K ﹤0.01% 936

Other funds holding SOPH

Harbor Investment Advisory's SOPH Position: Q2 2022 in Review

Harbor Investment Advisory sold out of SOPHiA GENETICS (SOPH) in Q2 2022, closing a stake of 1,439 shares — an estimated $11K sold.

Harbor Investment Advisory first reported a position in SOPH in Q4 2021 and held it in 2 quarters. The position peaked at $20K in Q4 2021. 34 funds tracked by Wall St. Rank hold SOPH as of Q2 2022.

  • Harbor Investment Advisory reported no remaining SOPHiA GENETICS position as of Q2 2022 after selling out during the quarter.
  • Harbor Investment Advisory sold 1,439 SOPHiA GENETICS shares in Q2 2022, an estimated $11K.
  • Harbor Investment Advisory first reported a position in SOPHiA GENETICS in Q4 2021 and held it in 2 quarters.
  • Harbor Investment Advisory's SOPHiA GENETICS position peaked at $20K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2022.

Based on Harbor Investment Advisory's 13F filing for Q2 2022, filed 18 Jul 2022.